CliffBio
small molecule

POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand namePOTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Active ingredientDEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
Strength5GM/100ML;150MG/100ML;900MG/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalApril 1985
Marketing statusRX

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.